Local biotech company
Biothera has been featured in the cover story of the journal Nature for their work with beta glucans, "immunomodulating compounds [that] prime the innate immune system to protect the body," according to language in a press release about the publication.
The
full text of the article is available for $32, but the article--titled
Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'--is not light reading.
Eagan-based Biothera is a pioneer in beta glucans research. Its Pharmaceutical Group is developing an immunomodulating drug that mobilizes the innate immune system to fight most types of cancer, states the release, and its Healthcare Group is a leading provider of natural immune health ingredients for nutrition markets.